Titan Pharmaceuticals (de) Total Revenue

Titan Pharmaceuticals (de) (TTNP) currently reports a total revenue of $0 as of December 2025. That compares with $10K in the prior-year period — down 100.0% year over year. That is below the Healthcare sector average of $110B. Use the charts on this page to explore Titan Pharmaceuticals (de)'s total revenue history and peer comparisons.

Titan Pharmaceuticals (de)'s total revenue decreased from $10K to $0 — a 100.0% year-over-year decrease (period ending December 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Titan Pharmaceuticals (de)'s total revenue of $0 is lower than the Healthcare sector average of $110B. That is roughly 100.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Titan Pharmaceuticals (de) reported $0 in total revenue as of December 2025. That compares with $10K in the prior-year period — down 100.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total revenue of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $110B. From there, open related valuation or income-statement pages for Titan Pharmaceuticals (de), and consider following TTNP for alerts when major investors trade the stock.